Based on these reports and our prediction, it is reasonable to speculate that magnolol can prevent the development of RV remodeling during PAH through mechanisms involving blocking the activation of the JAK2/STAT3 pathway. Here, JAK2 is linked to pulmonary arterial hypertension.